Nephro Care India Limited is launching an IPO with a fresh issue of 45,84,000 shares worth INR 41.26 crores. The company aims to establish “Vivacity Multi Specialty Hospital” in Kolkata and cover general corporate expenses.
Nephro Care IPO – Important Dates
| Nephro Care India Limited IPO Date | June 28, 2024, to July 2, 2024 |
| Nephro Care India Limited IPO Listing Date | July 5, 2024 |
| Nephro Care India Limited IPO Price | INR 85-90 per share |
| Nephro Care India Limited IPO Lot Size | 1600 shares |
| Nephro Care India Limited IPO Total Issue Size | INR 41.26 crores |
| Nephro Care India Limited IPO Basis of Allotment | July 3, 2024 |
| Nephro Care India Limited IPO Initiation of Refunds | July 4, 2024 |
| Nephro Care India Limited IPO Credit of Shares to Demat | July 4, 2024 |
| Nephro Care India Limited IPO Issue Type | Book Built Issue IPO |
| Nephro Care India Limited IPO Listing At | NSE SME |
Nephro Care India Limited IPO – Company Profile
Nephro Care India Limited, founded in 2014 by Dr. Pratim Sengupta in Kolkata, provides comprehensive renal care. The center offers clinical and lifestyle solutions supported by expert staff, focusing on scientific, transparent, and ethical treatment at affordable costs.
Their company, Nephro Care, operates a dialysis unit in Salt Lake City, Kolkata, and serves 900 CKD patients monthly. They’ve leased a 60-bed hospital in Madhyamgram to convert it into a 100-bed multi-specialty facility.
It provides in-house dialysis, outpatient services in nephrology, diabetology, cardiology, ophthalmology, and neurology, NABL-accredited pathology, pharmacy, advanced diagnostics, renal nutrition, home care, Mukti lifestyle support, and home dialysis services at its clinics.
Nephro Care India Ltd IPO Fundamental Analysis
Nephro Care India Limited Technologies’ financial analysis reveals a mixed performance. Revenue has significantly increased, equity and liabilities are up, profitability and EPS have improved, and RoNW and assets have risen, with stronger liquidity and better inventory turnover.
- Revenue Trend: The revenue increased from ₹342.44 lakhs in March 2022 to ₹1,709.27 lakhs in March 2023. The revenue for the current year’s 9-month period ending December 2023 is INR 1,975.14 lakhs, crossing last year’s benchmark.
- Equity and Liabilities: Both equity and liability have shown a consistent increase over the periods, reflecting potential growth and expansion. However, the debt-equity ratio has decreased, indicating reduced reliance on debt financing.
- Profitability: The profit after tax (PAT) has significantly increased from ₹(0.98) lakhs in March 2022 to ₹340.04 lakhs by December 2023. This improvement in profitability could be a source of confidence among investors.
- Earnings per Share (EPS): The diluted EPS has risen from ₹(0.03) in March 2022 to ₹3.36 by December 2023, reflecting higher earnings per share for investors.
- Return on Net Worth (RoNW): The RoNW has risen from (1.98)% to 24.42%, indicating an increase in the company’s ability to generate returns on shareholder equity.
- Financial Position: Total assets have increased, suggesting potential business growth. However, the current ratio has increased, indicating strengthening liquidity and potential challenges in meeting short-term obligations.
- Inventory Turnover Ratio: There’s an increase in the Inventory Turnover Ratio, which might suggest higher sales or efficient inventory management.
Nephro Care IPO Financial Analysis
| Particular | As of 31 March 2022 | As of 31 March 2023 | As of 31 December 2023 |
| Revenue (₹ in lakhs) | 342.44 | 1,709.27 | 1,975.14 |
| Equity (₹ in lakhs) | 49.52 | 243.76 | 1,392.32 |
| Expenses (₹ in lakhs) | 342.68 | 1,438.40 | 1,530.13 |
| Profit and Loss After Tax (₹ in lakhs) | (0.98) | 194.24 | 340.04 |
| Diluted EPS only (₹) | (0.03) | 1.94 | 3.36 |
| Return on Net Worth (%) | (1.98) | 79.68 | 24.42 |
| NAV per Equity Share (₹) | 0.50 | 2.44 | 11.70 |
| Total Assets (in lakhs) | 462.93 | 831.11 | 2,029.85 |
| Total Liabilities (in lakhs) | 413.41 | 587.35 | 637.53 |
| Debt Equity Ratio | 9.95 | 1.68 | – |
| Current Ratio (in times) | 0.66 | 0.86 | 0.87 |
| Inventory Turnover Ratio | 15.15 | 14.91 | 16.50 |
Nephro Care India Limited IPO Peer Comparison
No listed companies in India engage in a business similar to Nephro Care India Limited’s. Accordingly, it is impossible to provide an industry comparison for their company.
Nephro Care India Ltd IPO Objective
Nephro Care India Limited’s main objective is to establish “a “Vivacity Multi Specialty Hospital” in Kolkata, West Bengal, enhancing healthcare services in the region.
- Setting up a Multispeciality Hospital named “Vivacity Multi Specialty Hospital” (a unit of Nephro Care) at Kolkata (Madhyamgaram), West Bengal: The company intends to utilize INR 26.15 crores from IPO proceeds and internal accruals to establish Vivacity Multispecialty Hospital in Kolkata, offering 100 beds, advanced diagnostics, dialysis, surgical facilities, and specialized care services.
- General Corporate Purposes: The Company will deploy the balance of funds towards general corporate purposes, including meeting operating expenses, branding, promotion, advertisements, and unforeseen difficulties, to support its ordinary business operations and strategic goals.
Nephro Care IPO Risks And Challenges
Nephro Care India Limited’s risks include a lack of hospital experience, potential delays in hospital setup, heavy reliance on the Salt Lake clinic, and dependence on skilled healthcare professionals, which could impact operations, revenues, and profitability.
- Their Company plans to expand by setting up a 100-bed multispecialty hospital in Kolkata. However, lack of experience, potential delays, and unforeseen challenges may impact future operations, revenues, and profitability, posing significant risks.
- Their revenue heavily relies on their flagship Salt Lake clinic, which comprised 99% of the operations as of December 2023. Any adverse impact on patient footfall, regulatory changes, or regional economic challenges could significantly affect financial performance.
- Their operations depend on skilled healthcare professionals, including doctors and nurses. Attrition risks, competitive recruitment, and individual doctor preferences may impact service quality, patient volume, and clinic profitability, posing significant business challenges.
Nephro Care India Ltd IPO – Industry & Market Potential
In 2024, the global healthcare sector navigates unprecedented changes driven by the aftermath of COVID-19, AI integration for equity and efficiency, sustainability initiatives, telemedicine’s expanded role, and evolving cost and workforce dynamics reshaping healthcare delivery worldwide.
India’s healthcare industry, valued at USD 132 billion for hospitals by 2023, sees robust growth in medical tourism to USD 12.64 billion by 2028 and a USD 4 billion diagnostics sector with a 25% organized sector share.
Driven by long-term structural factors and government initiatives like PMJAY, India’s healthcare delivery market is poised to grow at a 10-12% CAGR, reaching Rs 8.6 trillion by fiscal 2027. Private sector dominance is expected to increase to nearly 70% by fiscal 2027, bolstered by rising medical tourism and lifestyle-related ailments.
Nephro Care India Limited IPO – Type of Offer
Nephro Care India Limited is launching an IPO with a fresh issue of 45,84,000 shares worth INR 41.26 crores. The company aims to establish “Vivacity Multi Specialty Hospital” in Kolkata and cover general corporate expenses.
Nephro Care India Ltd IPO Offer Size
The offer size of Nephro Care India Limited is INR 41.26 crores, consisting of a fresh issue of 45,84,000 shares. The company seeks funds to establish “Vivacity Multi Specialty Hospital” in Kolkata and cover general corporate expenses.
Nephro Care India Limited IPO Allotment Structure
Nephro Care India Limited’s allocation will be as follows: 50% for Qualified Institutional Buyers (QIB), 15% for Non-Institutional Investors (NII), and 35% for Retail Individual Investors (RII) according to SEBI regulations.
● Qualified Institutional Buyers (QIB): As per SEBI regulations, 50% of the shares offered through the IPO will be reserved for Qualified Institutional Buyers. These include entities such as banks, mutual funds, and insurance companies.
● Non-Institutional Investors (NII): 15% of the shares will be reserved for Non-Institutional Investors. These typically include corporate bodies or individuals investing more than Rs.2 lakhs.
● Retail Individual Investors (RII): The remaining 35% of the shares will be allotted to Retail Individual Investors. These individual investors apply for shares with a total value of less than Rs.2 lakhs.
How to apply for a Nephro Care India Limited IPO?
To apply for the Nephro Care India Limited IPO through Alice Blue, you would typically follow these steps:
Open a Demat and Trading Account: If you don’t have one already, you must open a Demat and trading account with Alice Blue.
- Check for IPO Details: Once your account is active, you can check for the Nephro Care India Limited IPO details in the IPO section of the Alice Blue platform.
- Place the Bid: Enter the number of shares you wish to buy and place your bid within the IPO’s price band.
- Submit the Application: Confirm all your details and submit your application.
You can apply for the Nephro Care India Limited IPO at Alice Blue in just a few clicks!
Check Allotment Status: After the allotment process, you can check the allotment status to see if you have received any shares.
Please note that the allotment of shares is not guaranteed and will depend on the demand for the IPO.
How do you check Nephro Care India Limited’s IPO Allotment Status?
Checking the allotment status of an IPO in Alice Blue is usually straightforward. Please follow these general steps:
- Log in to your Alice Blue Account: You can do this through the Alice Blue website or their trading app.
- Navigate to the Portfolio or IPO Section: This might differ based on the layout of Alice Blue’s platform, but generally, you can find the status of your IPO application under the ‘Portfolio’ or ‘IPO’ section.
- Find the IPO Allotment Status: Look for a sub-section called ‘IPO Allotment Status’ or something similar. This is where you can see the status of the IPOs you have applied for.
- Select the Nephro Care India Limited IPO: If you have applied for multiple IPOs, there might be a dropdown menu or a list where you can select the IPO you are interested in. Select the Nephro Care India Limited IPO.
- Check the Status: The status of your application should be displayed here. If the shares have been allocated to you, it would be mentioned here.
If you face any issues, it’s recommended that you contact Alice Blue’s customer support for detailed assistance.
Apart from Alice Blue, there are other ways to check the allotment status of the Nephro Care India Limited IPO:
● Registrar’s Website: Visit the website of Bigshare Services Private Limited, the registrar of the Nephro Care India Limited IPO. On the homepage, look for the ‘IPO Allotment Status’ option. You must enter your PAN, application, or Demat account number to check your allotment status. Click on the ‘Submit’ button to view your IPO allotment status.
● NSE SME: You can also check the allotment status on the official websites of the National Stock Exchange (NSE) Small Medium Exchange (SME). You would need your application number and PAN to check the status.
Please note that the allotment status will only be available after completing the allotment process, a few days after the IPO window closes.
Nephro Care India Limited Ltd IPO Offer Registrar
The registrar for the Nephro Care India Limited IPO is Bigshare Services Private Limited. They are responsible for ensuring the IPO allotment and refund processes are carried out smoothly.
Contact information for the registrar:
BIGSHARE SERVICES PRIVATE LIMITED
Office No. S6-2, 6th floor,
Pinnacle Business Park, Next to Ahura Centre,
Mahakali Caves Road, Andheri (East),
Mumbai- 400093
Tel: +91-22-62638200
Email: [email protected]
Website: www.bigshareonline.com
Nephro Care India Limited Limited IPO – FAQs
The allotment date of the Nephro Care India Limited IPO is July 3, 2024.
The price band of the issue is INR 85-90 per share.
The offer size of Nephro Care India Limited is INR 41.26 crores, consisting of a fresh issue of 45,84,000 shares. The company seeks funds to establish “Vivacity Multi Specialty Hospital” in Kolkata and cover general corporate expenses.
The listing date of Nephro Care India Limited’s IPO is July 5, 2024.
